AMPH vs. AVGO
Compare and contrast key facts about Amphastar Pharmaceuticals, Inc. (AMPH) and Broadcom Inc. (AVGO).
Performance
AMPH vs. AVGO - Performance Comparison
Loading graphics...
AMPH vs. AVGO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AMPH Amphastar Pharmaceuticals, Inc. | -26.85% | -27.88% | -39.97% | 120.74% | 20.31% | 15.81% | 4.25% | -3.07% | 3.43% | 4.45% |
AVGO Broadcom Inc. | -10.38% | 50.63% | 110.49% | 104.18% | -13.27% | 56.48% | 44.88% | 29.05% | 2.18% | 48.19% |
Fundamentals
AMPH:
$923.94M
AVGO:
$1.51T
AMPH:
$2.06
AVGO:
$5.13
AMPH:
9.52
AVGO:
60.31
AMPH:
0.50
AVGO:
0.75
AMPH:
1.30
AVGO:
22.06
AMPH:
1.17
AVGO:
18.94
AMPH:
$719.89M
AVGO:
$68.28B
AMPH:
$356.06M
AVGO:
$46.31B
AMPH:
$191.74M
AVGO:
$36.65B
Returns By Period
In the year-to-date period, AMPH achieves a -26.85% return, which is significantly lower than AVGO's -10.38% return. Over the past 10 years, AMPH has underperformed AVGO with an annualized return of 4.43%, while AVGO has yielded a comparatively higher 38.12% annualized return.
AMPH
- 1D
- 1.93%
- 1M
- -3.16%
- YTD
- -26.85%
- 6M
- -26.49%
- 1Y
- -32.42%
- 3Y*
- -19.46%
- 5Y*
- 1.61%
- 10Y*
- 4.43%
AVGO
- 1D
- 5.49%
- 1M
- -2.94%
- YTD
- -10.38%
- 6M
- -5.81%
- 1Y
- 86.36%
- 3Y*
- 71.23%
- 5Y*
- 48.36%
- 10Y*
- 38.12%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AMPH vs. AVGO — Risk / Return Rank
AMPH
AVGO
AMPH vs. AVGO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AMPH | AVGO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.66 | 1.80 | -2.46 |
Sortino ratioReturn per unit of downside risk | -0.73 | 2.52 | -3.25 |
Omega ratioGain probability vs. loss probability | 0.90 | 1.33 | -0.43 |
Calmar ratioReturn relative to maximum drawdown | -0.76 | 2.95 | -3.71 |
Martin ratioReturn relative to average drawdown | -1.67 | 7.31 | -8.98 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| AMPH | AVGO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.66 | 1.80 | -2.46 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.04 | 1.15 | -1.11 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.11 | 0.98 | -0.88 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.17 | 1.06 | -0.89 |
Correlation
The correlation between AMPH and AVGO is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
AMPH vs. AVGO - Dividend Comparison
AMPH has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.80%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMPH Amphastar Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AVGO Broadcom Inc. | 0.80% | 0.70% | 0.94% | 1.71% | 3.02% | 2.24% | 3.05% | 3.54% | 3.11% | 1.87% | 1.43% | 1.13% |
Drawdowns
AMPH vs. AVGO - Drawdown Comparison
The maximum AMPH drawdown since its inception was -72.04%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for AMPH and AVGO.
Loading graphics...
Drawdown Indicators
| AMPH | AVGO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.04% | -48.30% | -23.74% |
Max Drawdown (1Y)Largest decline over 1 year | -41.01% | -28.67% | -12.34% |
Max Drawdown (5Y)Largest decline over 5 years | -72.04% | -41.15% | -30.89% |
Max Drawdown (10Y)Largest decline over 10 years | -72.04% | -48.30% | -23.74% |
Current DrawdownCurrent decline from peak | -69.86% | -24.75% | -45.11% |
Average DrawdownAverage peak-to-trough decline | -23.32% | -8.00% | -15.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.61% | 11.56% | +7.05% |
Volatility
AMPH vs. AVGO - Volatility Comparison
Amphastar Pharmaceuticals, Inc. (AMPH) and Broadcom Inc. (AVGO) have volatilities of 12.83% and 12.64%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| AMPH | AVGO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.83% | 12.64% | +0.19% |
Volatility (6M)Calculated over the trailing 6-month period | 38.92% | 32.48% | +6.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.46% | 48.26% | +1.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.53% | 42.34% | +1.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 42.12% | 38.91% | +3.21% |
Financials
AMPH vs. AVGO - Financials Comparison
This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMPH vs. AVGO - Profitability Comparison
AMPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Amphastar Pharmaceuticals, Inc. reported a gross profit of 85.67M and revenue of 183.11M. Therefore, the gross margin over that period was 46.8%.
AVGO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Broadcom Inc. reported a gross profit of 13.16B and revenue of 19.31B. Therefore, the gross margin over that period was 68.1%.
AMPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Amphastar Pharmaceuticals, Inc. reported an operating income of 35.61M and revenue of 183.11M, resulting in an operating margin of 19.5%.
AVGO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Broadcom Inc. reported an operating income of 8.56B and revenue of 19.31B, resulting in an operating margin of 44.3%.
AMPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Amphastar Pharmaceuticals, Inc. reported a net income of 24.43M and revenue of 183.11M, resulting in a net margin of 13.3%.
AVGO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Broadcom Inc. reported a net income of 7.35B and revenue of 19.31B, resulting in a net margin of 38.1%.